1Siu C W, Lau C P, Tse H F. Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion[ J]. Am J Cardiol,2003, 92 ( 11 ) : 1343-1345.
3Young X Y ,Jabbour S, Goldberg R, et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease [ J ]. Am J Cardiol, 2003,92 ( 12 ) : 1379-1383.
4Ozaydin M,Varol E,Aslan S M,et al. Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical eardioversion[ J ]. Am J Cardiol,2006,97 ( 10 ) : 1490-1493.
5Hanna I R, Heeke B, Bush H, et al. The relationship between stature and the prevalence of atrial fibrillation in patients with left ventricular dysfunction [ J]. J Am Coil Cardiol, 2006,47 ( 8 ) : 1683-1688.
6Mitchell L B, Powell J L, Gillis A M, et al. Are lipid-lowering drugs also antiarrhythmic drugs.9 An analysis of the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial[J]. J Am Coil Cardiol,2003,42( 1 ) :81-87.
7Chiu J H,Abdelhadi R H,Chung M K,et al. Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator[ J]. Am J Cardiol,2005,95 (4) :490-491.
8Vyas A K, Guo H, Moss A J, et al. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) -Ⅱ[ J ]. J Am Coll C ardiol, 2006,47 ( 4 ) : 769-773.
9Lorenz H,Junger C, Seidl K, et al. Do statins influence the prognostic impact of non-sustained ventricular tachycardia after ST-elevation myocardial infarction? [ J]. Eur Heart J, 2005,26 ( 11 ) : 1078-1085
10Chung M K, Martin D O, Sprecher D,et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation[ J]. Circulation ,2001,104 (24) :2886-2891.
2Frustaci A,Chimenti C,Bellocci F,et al.Histological substrate of atrial biopsies in patients with lone atrial fibrillation.Circulation,1997,96:1180-1184.
3Aviles RJ,Martin DO,Hassen CA,et al.Inflammation as a risk factor for atrial fibrillation.Circulation,2003,108:3006-3010.
4Scalia R,Gooszen ME,Jones SP,et al.Simvastatin exerts both anti-imflammatory and cardioprotective.Effects in apolipoprotein E-deficient mice.Circulation,2001,103:2598-2603.
5van de Ree MA,Huisman MV,Princen HMG,et al.Strong decrease of high sensitivity C-reactive protein with high-dose atovastatin in patients with type 2 diabetes mellitus.Atherosclerosis,2003,166:129-135.
6Li D,Fareh S,Leung TK,et al.Promotion of atrial fibrillation by heart failure in dog:atrial remodeling of a different sort.Circulation,1999,100:87-95.
7Mihm MJ,Yu F,Cames CA,et al.Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation.Circulation,2001,104:174-180.
8Chung MK,Martin DO,Sprecher D,et al.C-reactive protein elevation in patients with atrial arrhythmias.Circulation,2001,104:2886-2891.
9Lefer AM,Campbell B,Shin YK,et al.Simvastatin preserves the ischemic-reperfused myocardium in normocholerterolemic rat hearts.Circulation,1999,100:178-184.
10Xu YY,Jabbour S,Goldberg k,et al.Usefulness of station drugs in protecting against atrial fibrillation in patients with CorOnary artery disease.Am J Cardiol,2003,92:1379-1383.
7Murata J, Kinoshita K, Hori M, et al. Statin protects endot belial nit tic oxide synthase activity in hyposia-induced pulmonary hypertension [ J]. Arterioscler Thromb Vasc Biol, 2005, 25 ( 11 ) :2335-2342.
8Schaeter C A, Kuhlmann C R, Weiterer S, et al. Statins inhibit hypoxia-induced endot belial proliferation by preventing calcium-induced ROS formation [ J ]. Atherosclerosis, 2006, 185(2) :290-296.
9Liao J K,Laufs U. Pleiotropic effect of statins[ I]. Annu Rev Pharmacol Toxicol, 2005,45 : 89-118.
10Tousoulis D, Antoniades C, Bosinakou E, et al. Effects of atorvastatin on reactive hyperemia and inflammatory process in patientswith congestive heart failure [ J ]. Atherosclerosis, 2005,178 ( 2 ) :359-363.
